Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: The China-PAR project. (1st December 2020)

• Record Type: Journal Article
• Authors: Wang, Xinyan; Liu, Fangchao; Li, Jianxin; Yang, Xueli; Chen, Jichun; Cao, Jie; Wu, Xigui; Lu, Xiangfeng; Huang, Jianfeng; Li, Ying; Zhao, Liancheng; Shen, Chong; Hu, Dongsheng; Yu, Ling; Liu, Xiaoqing; Wu, Xianping; Wu, Shouling; Gu, Dongfeng
• Is Part Of: European journal of preventive cardiology. Volume 27:Number 18(2020)
• Page Start: 1956
• Page End: 1963
• Publication Date: 2020-12-01
• Subjects: Tea consumption -- atherosclerotic cardiovascular disease -- all-cause mortality -- prospective cohort study -- Chinese population; Cardiovascular system -- Diseases -- Prevention -- Periodicals; Cardiac patients -- Rehabilitation -- Periodicals; 616.12
• DOI: 10.1177/2047487319894685
• Languages: English
• ISSNs: 2047-4873

Abstract

Abstract : Aims: The role of tea consumption in the primary prevention of atherosclerotic cardiovascular disease remains unclear in cohort studies. This prospective cohort study aimed to investigate the associations of tea consumption with the risk of atherosclerotic cardiovascular disease and all-cause mortality. Methods: We included 100, 902 general Chinese adults from the project of Prediction for ASCVD Risk in China (China-PAR) in 15 provinces across China since 1998. Information on tea consumption was collected through standardized questionnaires. Outcomes were identified by interviewing study participants or their proxies, and checking hospital records and/or death certificates. Cox proportional hazard regression models were used to calculate hazard ratios and their corresponding 95% confidence intervals related to tea consumption. Results: During a median follow-up of 7.3 years, 3683 atherosclerotic cardiovascular disease events, 1477 atherosclerotic cardiovascular disease deaths, and 5479 all-cause deaths were recorded. Compared with never or non-habitual tea drinkers, the hazard ratio and 95% confidence interval among habitual tea drinkers was 0.80 (0.75–0.87), 0.78 (0.69–0.88), and 0.85 (0.79–0.90) for atherosclerotic cardiovascular disease incidence, atherosclerotic cardiovascular disease mortality, and all-cause mortality, respectively. Habitual tea drinkers had 1.41 years longer of atherosclerotic cardiovascular disease-free years and 1.26 years longer of life expectancy at the index age of 50 years. The observed inverse associations were strengthened among participants who kept the habit during the follow-up period. Conclusion: Tea consumption was associated with reduced risks of atherosclerotic cardiovascular disease and all-cause mortality, especially among those consistent habitual tea drinkers.